Bitcoin is having a tough month and is currently trading around $73,500 and poised to close the month with losses of about 3%. The market is now being watched carefullyBitcoin is having a tough month and is currently trading around $73,500 and poised to close the month with losses of about 3%. The market is now being watched carefully

Bitcoin Price News: Bitcoin Faces a Key Test as ETF Outflows Top $1.42 Billion

2026/06/01 06:00
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Bitcoin is having a tough month and is currently trading around $73,500 and poised to close the month with losses of about 3%. The market is now being watched carefully by investors for any chance of a recovery that will help the market hold on to an important level.

There are several reasons behind this. ETFs experienced major inflows, futures markets are flooded with leveraged positions, and there is talk that another purchase of strategy will take place soon. 

Factors Driving the BTC Price Right Now

One of the biggest stories affecting the BTC price comes from the ETF market. Data shared by Crypto Patel shows that US spot Bitcoin ETFs recorded approximately $1.42 billion in net outflows between May 25 and May 29. 

Over that period, ETF providers collectively sold around 19,021 BTC. To put that into perspective, that amount represents roughly 42 days of newly mined Bitcoin supply. BlackRock led the outflows with about 12,757 BTC sold. Grayscale reduced holdings by around 2,741 BTC, Fidelity sold approximately 2,232 BTC, and other issuers also recorded net selling. 

Source: X/@cryptopatel

When institutions pull that much Bitcoin out of ETFs in a single week, it naturally raises concerns about near-term demand. While this happens, there is already talk that June might be a volatile month for the derivatives market.

The open interest for bitcoin futures contracts now stands at approximately $42.6 billion, with about $8.5 billion in options contracts that will expire on June 26. The estimated “max pain” range for these contracts lies within the $77,500 to $78,000 level.

Read Also: Charles Hoskinson’s Wild Bitcoin Price Prediction: $1.5M or $3M per Coin – Here’s the Math

Here’s What the BTC Chart Is Showing

We had a look at the MVRV Pricing Bands chart shared by Ali Martinez, and one level immediately stands out: $72,648. The MVRV framework examines the relationship between the market value and the realized value of bitcoin, which refers to the average cost at which coins were last transacted.

Source: X/@alicharts

As of now, the BTC price stands at approximately $73,530, representing only a 1.2% rise from the -0.5 sigma band of $72,648. In the past, this level has been a significant support region that offered favorable reward-risk dynamics for buyers.

That explains why Ali Martinez is paying such close attention to this level. If Bitcoin continues holding above it, the market may view the recent weakness as a normal correction within a larger cycle.

The next major support sits much lower. If $72,648 breaks, the MVRV model points to a demand zone between $54,300 and $51,000. Those levels line up closely with Bitcoin’s realized price of $54,273 and the -1.0 standard deviation band near $51,074. Looking upward, the MVRV mean band sits at $94,849. That’s considered the model’s fair-value level and represents nearly 29% upside from current prices.

Another long-term perspective comes from Benjamin Cowen’s logarithmic regression model. His analysis shows Bitcoin continuing to trade within its historical growth channel despite the correction from six-figure highs. The model also shows that each cycle tends to produce smaller percentage gains than the one before, a pattern that has persisted for more than a decade.

Where Could the BTC Price Go Next?

The answer depends largely on what happens around $72,650. If the BTC price holds above this level, the first major target remains the MVRV mean near $94,849. That would put Bitcoin back into its historical fair-value range and potentially restore confidence after a difficult month.

There is also support from derivatives positioning. With options markets heavily concentrated around the $77,500-$78,000 area, traders could see upward pressure develop if Bitcoin begins moving higher into June.

The bearish case becomes much stronger if support fails. A decisive break below $72,650 would put the focus on the next major demand zone between $54,300 and $51,000. That would represent a decline of roughly 26% to 30% from current levels and bring Bitcoin closer to the average cost basis of long-term holders. The next few weeks could play a major role in determining where the BTC price heads for the rest of 2026.

FAQs

Why are Bitcoin ETF flows important❓

Bitcoin ETFs provide institutional and retail investors with regulated exposure to BTC. Large inflows can increase demand for Bitcoin, while large outflows can create selling pressure as fund managers reduce their holdings.

How does futures open interest affect Bitcoin❓

Futures open interest measures the total value of active futures contracts. Bitcoin futures open interest is currently around $42.6 billion, indicating a large amount of leveraged exposure that could increase volatility.

Subscribe to our YouTube channel for daily crypto updates, market insights, and expert analysis.

The post Bitcoin Price News: Bitcoin Faces a Key Test as ETF Outflows Top $1.42 Billion appeared first on CaptainAltcoin.

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin is poised for a reversal if ETF demand returns or a ceasefire occurs, potentially crushing short sellers in a massive price squeeze.
Share
Coin Telegraph2026/04/04 19:58
Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Inertia is the invisible tax on modern industrial throughput. Every millisecond a robotic arm spends decelerating, or waiting for high-frequency vibrations to settle
Share
Techbullion2026/04/02 18:25

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage